Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

SABCS: Roche's Perjeta builds case as HER2-positive add-on

fiercepharmaDecember 12, 2019

Tag: Roche , HER2-positive , Breast Cancer

PharmaSources Customer Service